USPTO serial 79373988
3RND
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 29, 2024
- Examiner
- MANCA, ALBERTO I
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with 3RND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen White Zelano and Branigan PC2200 Clarendon Blvd Suite 1400Arlington, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research and development; scientific and technological services, namely, integrating phenotypic screening services and analysis for determining chemical toxicity risk in early research and development; Research and development relating to scientific and technological services, namely, chemical safety risk prediction for scientific research purposes by providing a cellular screening service for measuring the biological effect of a chemical in human cells, then using machine learning to translate the results into a risk probability, which is visualized using a cloud-based subscription service; Research, testing and analysis services, namely, analyzing the biological and cellular effect of a chemical and determining human toxicity risk by comparing to a training set using machine learning and sophisticated, cloud-based data visualization, for scientific research purposes; scientific research; scientific testing and analysis services in the field of drug discovery, industrial and agricultural chemicals, cosmetics, food safety, natural products and nutraceuticals; computer- aided scientific research; computer-aided scientific testing and analysis services in the field of chemistry, biology and toxicology; laboratory research and analysis services in the field of drug discovery, industrial and agricultural chemicals, cosmetics, food safety, natural products and nutraceuticals using machine learning and biological screening services to determine human and environmental safety risk; pharmaceutical research and development; scientific and technological services, namely, integrating cell-based screening services for scientific research purposes, analysis in the field of cloud-based machine learning, and visualization for chemical risk assessment as a service for scientific research purposes; scientific laboratory services; providing information about medical and scientific research in the field of pharmaceuticals; scientific research consulting, namely, preparation of reports on potential human safety risk of compounds early in drug discovery for the pharmaceutical industry, based on in vitro screening and machine-learning based risk probabilities in the fields of chemistry, biology and toxicology relating to scientific research; provision of information relating to technological research in the field of drug discovery, industrial and agricultural chemicals, cosmetics, food safety, natural products and nutraceuticals using cloud-based machine learning and biological screening services to determine human and environmental safety risk; providing information about industrial analysis and research services in the field of chemical design and modification to select, prioritize and progress safer chemicals for the chemical producing industries; provision of information relating to medical and veterinary research and development; provision of data, namely, providing an online database in the field of medical and veterinary research and development to determine human and animal safety risks; Chemical consultancy in the field of pharmaceutical research; pharmaceutical research consulting, namely, consultancy relating to research and development in the field of therapeutics; chemical engineering consultancy; providing technical advice in the field of scientific research; providing technical advice about industrial research in the field of chemical safety risk assessment; consultancy in the field of scientific research; consulting about industrial research in the field of chemical research and development for the development of new drugs, industrial and agricultural chemicals, and cosmetics; design and development of systems for data input, output, processing, display and storage; design and development of data display systems in the fields of chemistry, biology and toxicology; design and development of data processing systems; design and development of software for electronic databases; design and development of electronic databases; providing temporary use of a non-downloadable, cloud- based, software as a service (SaaS) services platform featuring software for storage, analysis and visualization of chemical structures and associated physical chemical property and biological data in the fields of chemistry, biology and toxicology; software as a service (SaaS) services platform incorporating mathematical and statistical algorithms featuring software for automated analysis and visualization of complex, multi-parameter physical chemical properties and biological data associated with chemicals; software as a service (SaaS) services featuring a software platform incorporating phenotypic screening with mathematical and statistical algorithms for automated analysis, prediction and visualization of human and environmental toxicity and safety risk; software as a service (SaaS) services featuring a software platform for uploading compound structures and linked high-content, multiparametric biological data and delivering novel visualization of the data; providing temporary use of non-downloadable cloud-based software as a service (SaaS) services featuring a software platform incorporating compound universe network visualizations for comparing the similarity between compounds based on their chemical structure and biological fingerprints; providing temporary use of non- downloadable cloud-based software as a service (SaaS) services featuring a software platform incorporating machine learning for predicting the toxicity and safety risks of a chemical based on automated analysis of the combination of the physical chemical descriptors of a compound coupled with the measured biological effect; software as a service (SaaS) services featuring a software platform that incorporates multiple features for uploading and drawing chemical structures and visualizing associated data uploaded for those chemicals; providing temporary use of non-downloadable cloud based software as a service (SaaS) services featuring a software platform incorporating compound universe network visualizations for comparing similarity of compounds based on chemical structure and biological fingerprints; providing temporary use of non-downloadable cloud-based software as a service (SaaS) services featuring a software platform enabling eCommerce capabilities for online ordering of chemicals, cellular and biological screening services and third-party software applications; software as a service (SaaS) services featuring a software platform for allowing multiple users across a network to simultaneously access and view chemical structures and their associated biological data and physical chemical properties; software as a service (SaaS) services featuring a software platform for enabling the upload, analysis and visualization of scientific data in the fields of chemistry, biology and toxicology; software as a service (SaaS) services, namely, hosting a software platform for use by others for integrating multiparametric cellular or phenotypic screening data linked to chemical structures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 29, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 13, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 13, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 18, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 18, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 18, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 18, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 18, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 1, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 1, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 30, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 18, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 13, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |